Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Johnson & Johnson
On this tag page, you will find four Johnson & Johnson articles covering dividends, growth paths, and valuation targets. Learn how these insights can shape smarter, cost-aware investing.
14 articles
Verizon vs Johnson & Johnson: Which Dividend Hike Wins?
Verizon raises its dividend with a high yield, while Johnson & Johnson offers steadier growth and a long payout histo...